A randomised controlled trial of a mindfulness intervention for men with advanced prostate cancer

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Chambers, Suzanne K ^a,b,c,d   Smith, David P ^d,e   Berry, Martin ^d,f   Lepore, Stephen J ^g   Foley, Elizabeth ^h   Clutton, Samantha ^b,d   McDowall, Robert ^b,d   Occhipinti, Stefano ^d,i   Frydenberg, Mark ^d,j,k   Gardiner, Robert A ^d,l,m  

^a GRIFFITH UNIVERSITY   (Australia)

^b CANCER COUNCIL QUEENSLAND   (Australia)

^c PROSTATE CANCER FOUNDATION OF AUSTRALIA   (Australia)

^d Australian and New Zealand Urogenital and Prostate Cancer Trials Group   (Australia)

^e CANCER RESEARCH DIVISION   (Australia)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

^g TEMPLE UNIVERSITY   (United States)

^h Mind Potential   (Australia)

ⁱ GRIFFITH UNIVERSITY   (Australia)

^j MONASH UNIVERSITY   (Australia)

^k ROYAL MELBOURNE HOSPITAL   (Australia)

^l UNIVERSITY OF QUEENSLAND   (Australia)

^m ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

more..

Author keywords

Health outcomes; Mental health; Prostate cancer; Psychological distress; Quality of life; Randomised controlled trial (RCT); Supportive care

Indexed keywords

ADVANCED CANCER; ANXIETY; ARTICLE; BENEFIT FINDING; CANCER THERAPY; COGNITIVE THERAPY; CONTROLLED STUDY; DEPRESSION; DISTRESS SYNDROME; HUMAN; MALE; MINDFULNESS BASED COGNITIVE THERAPY; OUTCOME ASSESSMENT; PATIENT EDUCATION; PROSTATE CANCER; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SELF REPORT; TELETHERAPY; ADULT; AUSTRALIA; MENTAL STRESS; PATHOLOGY; PREVENTION AND CONTROL; PROCEDURES; PROSTATIC NEOPLASMS; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANXIETY; AUSTRALIA; COGNITIVE THERAPY; DEPRESSION; HUMANS; MALE; PROSTATIC NEOPLASMS; QUALITY OF LIFE; STRESS, PSYCHOLOGICAL;

EID: 84874214464     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-89     Document Type: Article

References (24)

1. Australian Institute of Health and Welfare, Australasian Association of Cancer Registries Cancer in Australia: An overview, 2006 2007, Canberra: Australian Institute of Health and Welfare, Cancer Series AIHW cat no CAN 32, Australian Institute of Health and Welfare, Australasian Association of Cancer Registries.
2. Alam N, You H, Banks C, Baker D, Bishop J. Prostate Cancer in New South Wales 2009, Sydney: Cancer Institute NSW.
3. Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol 2003, 169(2):517-523. 10.1016/S0022-5347(05)63946-8, 12544300.
4. Australian Cancer Network Management of Metastatic Prostate Cancer Working Party Clinical practice guidelines for the management of locally advanced and metastatic prostate cancer 2010, Sydney: Cancer Council Australia and Australian Cancer Network, Australian Cancer Network Management of Metastatic Prostate Cancer Working Party.
5. Eton DT, Lepore SJ. Prostate cancer and health-related quality of life: a review of the literature. Psychooncology 2002, 11(4):307-326. 10.1002/pon.572, 2593110, 12203744.
6. Bloch S, Love A, Macvean M, Duchesne G, Couper J, Kissane D. Psychological adjustment of men with prostate cancer: a review of the literature. Biopsychosoc Med 2007, 1:2. 10.1186/1751-0759-1-2, 1805773, 17371571.
7. Bill-Axelson A, Garmo H, Lambe M, Bratt O, Adolfsson J, Nyberg U, Steineck G, Stattin P. Suicide risk in men with prostate-specific antigen-detected early prostate cancer: a nationwide population-based cohort study from PCBaSe Sweden. Eur Urol 2010, 57(3):390-395. 10.1016/j.eururo.2009.10.035, 19914773.
8. Fang F, Keating NL, Mucci LA, Adami H, Stampfer MJ, Valdimarsdottir U, Fall K. Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the United States. J Natl Cancer Inst 2010, 102(5):307. 10.1093/jnci/djp537, 20124521.
9. Chambers SK, Pinnock C, Lepore SJ, Hughes S, O'Connell DL. A systematic review of psychosocial interventions for men with prostate cancer and their partners. Patient Educ Couns 2011, 85(2):e75-88. 10.1016/j.pec.2011.01.027, 21334159.
10. Lau MA, Segal ZV, Williams JMG. Teasdale's differential activation hypothesis: implications for mechanisms of depressive relapse and suicidal behaviour. Behav Res Ther 2004, 42:1001-1017. 10.1016/j.brat.2004.03.003, 15325898.
11. Sheppard LC, Teasdale JD. How does dysfunctional thinking decrease during recovery from major depression?. J Abnorm Psychol 2004, 113:64-71.
12. Dobkin PL. Mindfulness-based stress reduction: what processes are at work?. Complement Ther Clin Pract 2008, 14(1):8-16. 10.1016/j.ctcp.2007.09.004, 18243937.
13. McKenzie MJ, Carlson LE, Munoz M, Speca M. A qualitative study of self perceived effects of mindfulness based stress reduction in a psychosocial oncology setting. Stress and Health 2007, 23(1):59-69.
14. Chambers SK, Foley E, Galt E, Ferguson M, Clutton S. Mindfulness groups for men with advanced prostate cancer: a pilot study to assess feasibility and effectiveness and the role of peer support. Support Care Cancer 2012, 20(6):1183-1192. 10.1007/s00520-011-1195-8, 21625914.
15. Segal ZV, Williams JMG, Teasdale JD. Mindfulness-based cognitive therapy for depression: a new approach to preventing relapse 2002, New York: Guilford Press.
16. Kabat-Zinn J. Full catastrophe living: using the wisdom of your body and mind to face stress, pain, and illness 1990, New York: Delacorte.
17. Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med 2010, 8:18. 10.1186/1741-7015-8-18, 2860339, 20334633.
18. Baer RA, Smith GT, Hopkins J, Krietemeyer J, Toney L. Using self-report assessment methods to explore facets of mindfulness. Assessment 2006, 13(1):27-45. 10.1177/1073191105283504, 16443717.
19. Derogatis LR. BSI-18: Administration, Scoring and Procedures Manual 2000, Minneappolis MN: National Computer Systems.
20. Horowitz M, Wilner N, Alvarez W. Impact of event scale: a measure of subjective stress. Psychosom Med 1979, 41(3):209-218.
21. Weiss DS, Marmar CR. The Impact of Events Scale - Revised. Assessing Psychological Trauma and PTSD 1997, 399-411. New York: Guilford Press, Wilson JP, Keane TM.
22. Roth AJ, Rosenfeld B, Kornblith AB, Gibson C, Scher HI, Curley-Smart T, Holland JC, Breitbart W. The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with prostate cancer. Cancer 2003, 97(11):2910-2918. 10.1002/cncr.11386, 12767107.
23. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 1993, 11(3):570-579.
24. Tedeschi RG, Calhoun LG. The posttraumatic growth inventory: measuring the positive legacy of trauma. J Trauma Stress 1996, 9(3):455-471. 10.1002/jts.2490090305, 8827649.